286 results on '"Avalos, Belinda R."'
Search Results
2. Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies
3. Survival following allogeneic transplant in patients with myelofibrosis
4. Altered expression of CSF3R splice variants impacts signal response and is associated with SRSF2 mutations
5. Hematopoietic Growth Factors in the Supportive Care and Treatment of Patients with Hematologic Neoplasms
6. Allogeneic hematopoietic cell transplantation; the current renaissance
7. Investigation of a gene signature to predict response to immunomodulatory derivatives for patients with multiple myeloma: an exploratory, retrospective study using microarray datasets from prospective clinical trials
8. Use of molecular markers to determine postremission treatment in acute myeloid leukemia with normal cytogenetics
9. Comparison of Outcomes of Allogeneic Transplantation for Chronic Myeloid Leukemia with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan, or Total Body Irradiation
10. Impact of Race, Ethnicity, and Social Determinants of Heath on Outcomes for Acute Myeloid Leukemia Patients in a System with Specialized Nurse Navigation
11. Factors Predicting Efficacy and Toxicity of Post Transplantation Cyclophosphamide for Graft Versus Host Disease Prevention in Hematopoietic Cell Transplantation Recipients: Interim Data of an Ongoing Study
12. Clonal Hematopoiesis Prevalence and Mutational Spectrum in Patients with Plasma Cell Disorders at the Time of Diagnosis and Its Impact on Clinical Features, Cardiovascular Complications, and Survival
13. Heterodimerization of CSF3R Splice Variants and Mutants Alter Receptor Function
14. Hematopoietic Growth Factors in the Supportive Care and Treatment of Patients with Hematologic Neoplasms
15. Outcomes and hospitalization patterns of patients with acute myelogenous leukemia treated with frontline CPX-351 or HMA/venetoclax
16. Hematopoietic Growth Factors in the Supportive Care and Treatment of Patients with Hematologic Neoplasms
17. How Many Stem Cells Are Sufficient for Engraftment?
18. Optimization of physician and specialty pharmacy clinical workflow in assessment of risk category and symptom burden in patients with myelofibrosis (MF)
19. Can G-CSF Cause Leukemia in Hematopoietic Stem Cell Donors?
20. Clinical Characteristics and Outcomes of AML Patients Treated with Frontline CPX 351 or HMA/Venetoclax: A Single Institution's Experience
21. CSF3R Splicing Regulates Granulopoiesis Via Splice Variant Specific Responses to G-CSF
22. Platform Incorporating Patient Navigation, Preparative Guidelines, and Hospital at Home May Improve COVID-19 Outcomes for Patients with Myeloid Malignancies
23. Equal access to care and nurse navigation leads to equitable outcomes for minorities with aggressive large B‐cell lymphoma
24. Late Mortality and Relapse following BuCy2 and HLA-Identical Sibling Marrow Transplantation for Chronic Myelogenous Leukemia
25. Role of the proteasome in modulating native G-CSFR expression
26. Should busulfan now be part of the standard treatment for patients with acute myeloid leukemia?
27. Altered splicing and intronic polyadenylation of CSF3R via a cryptic exon in acute myeloid leukemia
28. Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantation
29. Impact of Letermovir Prophylaxis on Voriconazole Exposure in Allogeneic Hematopoietic Cell Transplant Recipients
30. Complex CSF3R Protein Isoform Interactions Dictate Cytokine Responsiveness
31. Impact of Letermovir Prophylaxis on Voriconazole Exposure in Allogeneic Hematopoietic Cell Transplant Recipients
32. Characteristics Affecting Durability and Tolerability of Imatinib in Patients Switched from Brand to Generic and Newly Diagnosed Patients Initially Prescribed Generic Imatinib for Chronic Myeloid Leukemia
33. Specialty Pharmacy and Physician Partnership Optimizes Clinical Pathway Adherence in Myelofibrosis (MF): Initial Analysis of a Quality Improvement Initiative
34. Hematopoietic Growth Factors in the Supportive Care and Treatment of Patients with Hematologic Neoplasms
35. High Disease Burden Is Associated with Poor Outcomes for Patients with Acute Myeloid Leukemia Not in Remission Who Undergo Unrelated Donor Cell Transplantation
36. Abstract 1920: Response to hypomethylating agents based on cytidine deaminase expression, genetic polymorphisms, and NPM1 mutation status in acute myeloid leukemia
37. Favorable Survival Outcomes in Acute Myeloid Leukemia (AML) Patients (pts) Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT) without Achieving Complete Remission (CR) to Non-Intensive Chemotherapy
38. CXCL12-CXCL4 heterodimerization prevents CXCL12-driven breast cancer cell migration
39. T618I CSF3R mutations in chronic neutrophilic leukemia induce oncogenic signals through aberrant trafficking and constitutive phosphorylation of the O-glycosylated receptor form
40. Patient Reported Financial Toxicity in Myeloproliferative Neoplasms
41. Minorities Do Not Have Worse Outcomes for Diffuse Large B Cell Lymphoma (DLBCL) If Optimally Managed
42. New Germline Syndrome Discovery: Heterozygous CSF3R Mutations May Predispose to Myeloid and Lymphoid Malignancies
43. Alternative Splicing and Intronic Polyadenylation Post-Transcriptionally Regulate CSF3R Via a Cryptic Exon
44. Incidence and reasons for late failure after allogeneic haematopoietic cell transplantation following BuCy2 in acute myeloid leukaemia
45. Altered expression of CSF3R splice variants impacts signal response and is associated with SRSF2 mutations
46. Curative potential of chemoimmunotherapy in diffuse large B cell lymphoma with hepatic and/or renal dysfunction
47. Peripheral Immunotype Correlates with Minimal Residual Disease Status and Is Modulated by Immunomodulatory Drugs in Multiple Myeloma
48. Neutrophil elastase downmodulates native G-CSFR expression and granulocyte-macrophage colony formation
49. Human Natural Killer Cells Produce Abundant Macrophage Inflammatory Protein-1 alpha in Response to Monocyte-derived Cytokines
50. Chronic neutrophilic leukemia in a child with a CSF3R T618I germ line mutation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.